Nasdaq 100 Stocks SEC Filings — April 03, 2026

03-04-2026

Radian Group Inc. filed an 8-K/A on April 3, 2026, amending its February 12, 2026 8-K to disclose compensation for Daniel Kobell, appointed Senior Executive Vice President and Interim Chief Financial Officer effective February 12, 2026. The Compensation and Human Capital Management Committee approved an annual base salary of $500,000 effective February 21, 2026, eligibility for short-term incentives at 100% of base salary (prorated), and a target long-term equity incentive award of $1,000,000 for 2026.

• ·Compensation arrangements approved on March 30, 2026, by the Compensation and Human Capital Management Committee.
• ·Amounts and targets subject to future review and change.

03-04-2026

Mondelez International, Inc. (MDLZ) filed DEFA14A Definitive Additional Proxy Soliciting Materials on April 03, 2026, as part of proxy statement activities ahead of a shareholder meeting. The document contains encoded proxy voting instructions and graphics but no discernible specific proposals or financial metrics. No period-over-period comparisons or performance data are present.

• ·Central Index Key: 0001103982
• ·Fiscal Year End: 1231
• ·State of Incorporation: IL
• ·Business Address: 905 West Fulton Market Street, Suite 200, Chicago, IL 60607

03-04-2026

Aditxt, Inc. (ADTX) filed a DEF 14A proxy statement for its virtual-only 2026 Annual Meeting on May 1, 2026 at 12:00 p.m. ET, with a record date of March 26, 2026, when 861,482 shares of common stock were outstanding. Stockholders will vote on electing five directors, ratifying dbbmckennon as auditors for FY 2026, advisory say-on-pay and say-on-frequency proposals, authorizing a reverse stock split (1:2 to 1:250 ratio at board discretion within one year), and potential adjournment.

• ·Quorum requires one-third of shares entitled to vote.
• ·Proxy voting deadline: 11:59 p.m. ET on April 30, 2026.
• ·Default proxy votes: FOR all proposals except say-on-frequency (every 3 years).

03-04-2026

Lyell Immunopharma, Inc. filed an S-3 registration statement on April 3, 2026, to register 1,952,360 shares of common stock for resale by selling stockholders, consisting of shares issued at the Milestone Closing of a July 24, 2025 private placement at $25.61 per share. The company will receive no proceeds from these resales and previously issued 3,753,752 shares at the Initial Closing at $13.32 per share. Selling stockholders include ARCH Venture Fund XIII, L.P., Euler Fund, L.P., Gates Frontier, LLC, and Explore Investments LLC, with post-offering beneficial ownership ranging from 4.0% to 11.8% based on 23,328,390 shares outstanding as of March 31, 2026.

• ·Selling stockholders have no current positions or offices with Lyell or affiliates, except historical board service by Robert Nelsen until May 2025.
• ·Company incorporated in June 2018; principal offices at 201 Haskins Way, South San Francisco, CA.
• ·Nasdaq symbol: LYEL.

03-04-2026

Arcadia Biosciences, Inc. dismissed Deloitte & Touche LLP as its independent registered public accounting firm on March 30, 2026, and simultaneously engaged Ramirez Jimenez International CPAs (RJI) as its successor, effective immediately for the quarter ending March 31, 2026. There were no disagreements with Deloitte on accounting principles or auditing scope, but Deloitte's prior audit reports included a going concern explanatory paragraph due to accumulated deficits, recurring losses, and insufficient cash resources, alongside disclosed material weaknesses in internal controls. Deloitte provided a confirming letter as Exhibit 16.1.

• ·Material weaknesses in internal controls as of December 31, 2025, involved insufficient segregation of duties in financial close process and inadequate information system controls (access and change management), attributed to reduced employee headcount.
• ·No consultations with RJI occurred in the two most recent fiscal years or interim period regarding accounting, auditing, or reporting matters.
• ·10-K for year ended December 31, 2025, filed March 26, 2026, disclosed the material weaknesses in Item 9A.

03-04-2026

Camden National Corporation's definitive proxy statement for the 2026 Annual Meeting of Shareholders, to be held virtually on May 19, 2026, seeks approval for the election of eleven directors for one-year terms, a non-binding advisory 'Say-on-Pay' vote on named executive officer compensation, and ratification of RSM US LLP as independent auditors for the year ending December 31, 2026. The record date for shareholders entitled to vote is March 25, 2026. No financial performance metrics, period-over-period comparisons, or compensation figures are detailed in the provided filing content.

• ·Annual Meeting date: Tuesday, May 19, 2026, at 9:00 a.m. Eastern Daylight Time, virtual via www.virtualshareholdermeeting.com/CAC2026.
• ·Record date: Close of business on March 25, 2026.
• ·Filing date: April 3, 2026.

03-04-2026

On March 30, 2026, Intel Corporation announced that April Miller Boise, its Executive Vice President and Chief Legal Officer, will separate from the company effective June 1, 2026. Ms. Miller Boise will receive severance benefits under the Intel Corporation Executive Severance Plan in exchange for a release of claims. The Form 8-K was filed on April 3, 2026, and signed by David Zinsner, Executive Vice President and Chief Financial Officer.

• ·Date of earliest event reported: March 30, 2026
• ·Items reported: 5.02 (Departure of Directors or Certain Officers) and 9.01 (Financial Statements and Exhibits)

03-04-2026

Adirondack Trust Co filed its Form 13F-HR on April 03, 2026, disclosing institutional equity holdings as of March 31, 2026, consisting of 631 positions with a total market value of $297620445. The diversified portfolio spans sectors including information technology, financials, healthcare, consumer discretionary, and industrials, with notable holdings in Apple Inc., Amazon.com Inc., Berkshire Hathaway Inc., and others. No period-over-period changes or performance metrics are provided in the filing.

• ·Business address: 473 Broadway, Saratoga Springs, NY 12866
• ·Phone: 518-584-5844
• ·SEC file number: 028-11929
• ·Holdings include both SOLE and SHDFND voting authority positions across domestic and foreign issuers

03-04-2026

Token Communities Ltd. (TKCM) reported total revenues of $356,579 for the year ended June 30, 2025, an 85% YoY decline from $2,428,672, driven by home sales dropping 87% to $315,000, leading to a net loss of $464,107 versus net income of $1,276,464 in 2024 and gross margin shrinking 98% to $18,499. Total assets grew 51% to $6,037,968, supported by inventory up 47% to $5,818,102 and new construction in progress of $157,025, while cash ended at $62,841, up 142% from $25,939. However, liabilities rose 29% to $11,241,899 including a new $3,170,549 construction loan, widening stockholders' deficit to $5,203,931 from $4,740,500.

• ·Shares outstanding: 2,095,671,162 both periods.
• ·Net cash used in investing activities: $(157,025) FY2025 vs $0 FY2024.
• ·Acquisition of ASC Global Inc in FY2024 involved $5,000,000 notes payable and net assets of $320,010.
• ·Audit procedures focused on construction costs including testing disbursements and vendor confirmations.